Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Astal Laboratories Ltd.
Swot
Astal Laboratories Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Astal Laboratories Ltd. has 27 Strengths, 2 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(27)
Weakness
(2)
Opportunity
(0)
Threats
(0)
Others
(2)
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Strong Performer, Under Radar Stocks (DVM)
Companies with 10% increase in share price over three months, with rising net profit growth
Undervalued Growth Stocks
Consistent Highest Return Stocks over Five Years - Nifty500
Stocks with Consistent Share Price Growth (subscription)
Companies with high TTM EPS Growth
Strong Annual EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Companies with rising net profit margins - quarterly as well as TTM basis
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Increasing Revenue every Quarter for the past 4 Quarters
Increasing profits every quarter for the past 4 quarters
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Highest Recovery from 52 Week Low
Top Gainers
Stocks Outperforming their Industry Price Change in the Quarter
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Increasing Trend in Non-Core Income
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks